MetLife Investment Management’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,783
Closed -$146K 2866
2024
Q3
$146K Buy
+12,783
New +$146K ﹤0.01% 2450